Grants and Contributions:
Title:
Implementing Biomarkers for diagnostics and therapeutic evaluation and monitoring
Agreement Number:
1023399
Agreement Value:
$75,000.00
Agreement Date:
Sep 1, 2024 - Jun 30, 2025
Description:
Pathway Rx is developing bioinformatics processes that allow to analyze and integrate multiple sources of information – genomics, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics. The outcome will be the diagnostic and therapeutic efficiency software, allowing biomarkers-based diagnosis of various conditions and the ability to monitor the efficiency of treatments.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T3H 4Z2
Reference Number:
172-2024-2025-Q3-1023399
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
725412480
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 150 days.
Amendment Date
Feb 13, 2025
Recipient's Legal Name:
Pathway Rx Inc.
Federal Riding Name:
Calgary Signal Hill
Federal Riding Number:
48012
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
62151
Amendments: